logo
logo

DLA Piper advises Locanabio in its US$100 million Series B financing

Dec 15, 2020•over 4 years ago

Amount Raised

$100 Million

Round Type

series b

New York

Description

 DLA Piper represented Locanabio, an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with severe neurodegenerative, neuromuscular and retinal diseases, in its recent US$100 million Series B financing led by Vida Ventures.

Company Information

Company

Dla Piper

Location

New York, New York, United States

About

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising. dlapiper.com SOURCE DLA Piper

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People